Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | MAP2K1 |
Variant | L98_K104delinsQ |
Impact List | indel |
Protein Effect | gain of function |
Gene Variant Descriptions | MAP2K1 L98_K104delinsQ results in the deletion of seven amino acids in the protein kinase domain of the Map2k1 protein from amino acids 98 to 104, combined with the insertion of a glutamine (Q) at the same site (UniProt.org). L98_K104delinsQ results in increased activation of Map2k1 and elevated phosphorylation of Erk and Akt in culture (PMID: 29768711), and has been demonstrated to confer resistance to Mek inhibitors (PMID: 29768711). |
Associated Drug Resistance | Y |
Category Variants Paths |
MAP2K1 mutant MAP2K1 act mut MAP2K1 L98_K104delinsQ |
Transcript | NM_002755.4 |
gDNA | chr15:g.66436747_66436764del18 |
cDNA | c.293_310del18 |
Protein | . |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_017022411.3 | chr15:g.66436747_66436764del18 | c.293_310del18 | . | RefSeq | GRCh38/hg38 |
NM_002755 | chr15:g.66436747_66436764del18 | c.293_310del18 | . | RefSeq | GRCh38/hg38 |
NM_002755.4 | chr15:g.66436747_66436764del18 | c.293_310del18 | . | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|